AHMED MAHIUDDIN (Sr. VP and CSO) sold 25.0% of their position (50K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.97M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/27/2020ACC: 0001104659-20-066408
Officer· Sr. VP and CSO
Since Jan 2020
-50K
Net shares
Net seller
$1.97M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−50K
Price / share
$39.38
Trade value
$1.97M
% of position
25.0%
5/26/2020
200K→150K
Total
Net shares
−50K
Net value
-$1.97M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2020 | S · Sale | −50K | $39.38 | $1.97M | 25.0% | 200K | 150K |
| Total | −50K | -$1.97M | ||||||
Derivative Transactions0
No derivative transactions reported